A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis
Rong Li,Michela Colombo,Guanlin Wang,Antonio Rodriguez-Romera,Camelia Benlabiod,Natalie J. Jooss,Jennifer O'Sullivan,Charlotte K. Brierley,Sally-Ann Clark,Juan M. Pérez Sáez,Pedro Aragón Fernández,Erwin M. Schoof,Bo Porse,Yiran Meng,Abdullah O. Khan,Sean Wen,Pengwei Dong,Wenjiang Zhou,Nikolaos Sousos,Lauren Murphy,Matthew Clarke,Aude-Anais Olijnik,Zoë C. Wong,Christina Simoglou Karali,Korsuk Sirinukunwattana,Hosuk Ryou,Ruggiero Norfo,Qian Cheng,Joana Carrelha,Zemin Ren,Supat Thongjuea,Vijay A. Rathinam,Anandi Krishnan,Daniel Royston,Gabriel A. Rabinovich,Adam J. Mead,Bethan Psaila
DOI: https://doi.org/10.1126/scitranslmed.adj7552
IF: 17.1
2024-10-10
Science Translational Medicine
Abstract:Myeloproliferative neoplasms are stem cell–driven cancers associated with a large burden of morbidity and mortality. Most patients present with early-stage disease, but a substantial proportion progress to myelofibrosis or secondary leukemia, advanced cancers with a poor prognosis and high symptom burden. Currently, it remains difficult to predict progression, and therapies that reliably prevent or reverse fibrosis are lacking. A major bottleneck to the discovery of disease-modifying therapies has been an incomplete understanding of the interplay between perturbed cellular and molecular states. Several cell types have individually been implicated, but a comprehensive analysis of myelofibrotic bone marrow is lacking. We therefore mapped the cross-talk between bone marrow cell types in myelofibrotic bone marrow. We found that inflammation and fibrosis are orchestrated by a "quartet" of immune and stromal cell lineages, with basophils and mast cells creating a TNF signaling hub, communicating with megakaryocytes, mesenchymal stromal cells, and proinflammatory fibroblasts. We identified the β-galactoside–binding protein galectin-1 as a biomarker of progression to myelofibrosis and poor survival in multiple patient cohorts and as a promising therapeutic target, with reduced myeloproliferation and fibrosis in vitro and in vivo and improved survival after galectin-1 inhibition. In human bone marrow organoids, TNF increased galectin-1 expression, suggesting a feedback loop wherein the proinflammatory myeloproliferative neoplasm clone creates a self-reinforcing niche, fueling progression to advanced disease. This study provides a resource for studying hematopoietic cell–niche interactions, with relevance for cancer-associated inflammation and disorders of tissue fibrosis.
cell biology,medicine, research & experimental